Pharmala Biotech Holdings Inc. (CSE: MDMA)
Canada
· Delayed Price · Currency is CAD 0.255
-0.015 (-5.56%)
Jan 21, 2025, 11:10 AM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 22.17 million as of January 21, 2025. Its market cap has increased by 50.09% in one year.
Market Cap
22.17M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 22.17M, an increase of 233.95%. That is a compound annual growth rate of 48.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 23.48M | 8.00% |
| Dec 31, 2024 | 21.74M | 78.67% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.54B |
| Curaleaf Holdings | 1.63B |
| WELL Health Technologies | 1.61B |
| dentalcorp Holdings | 1.54B |
| Trulieve Cannabis | 1.37B |
| Sienna Senior Living | 1.26B |
| Cronos Group | 1.09B |
| Extendicare | 856.37M |